Slc2a12 | solute carrier family 2 (facilitated glucose transporter), member 12
Physiological systems
17 / 24 physiological systems tested
1 Significantly impacted by the knock-out
Cardiovascular system
16 No significant impact
7 Not tested
Data collections
Gene metrics:2Significant phenotypes
0Associated diseases
Expression examined in:0Adult tissues
0Embryo tissues
| increased heart left ventricle size | 1 supporting dataset | Slc2a12em2(IMPC)Bay | homozygote | Early adult | 2.64x10-5 | ||
| thick ventricular wall | 1 supporting dataset | Slc2a12em2(IMPC)Bay | homozygote | Early adult | 5.62x10-5 |
| | | | | | | | | | |
Human diseases caused by Slc2a12 mutations
The analysis uses data from IMPC, along with published data on other mouse mutants, in comparison to human disease reports in OMIM, Orphanet, and DECIPHER.
Phenotype comparisons summarize the similarity of mouse phenotypes with human disease phenotypes.
External links
No external links available for Slc2a12.
All available products are supplied via our member's centres or partnerships. When ordering a product from the IMPC you will be redirected to one of their websites or prompted to start an email.
| Slc2a12em1(IMPC)Bay | | mouse | |
| Slc2a12em2(IMPC)Bay | Exon Deletion | | mouse |
| Slc2a12tm360435(L1L2_Bact_P) | KO first allele (reporter-tagged insertion with conditional potential) | | targeting vector |